التداخل بين غليبيزيد وبروبينيسيد وكولشيسين

…angiotensin II receptor blocking agents, disopyramide, fibrates, fluoxetine, monoamine oxidase inhibitors, pentoxifylline, pramlintide, propoxyphene, salicylates, somatostatin analogs (e.g., octreotide), sulfonamide antibiotics, nonsteroidal anti-inflammatory agents, chloramphenicol, probenecid, coumarins, voriconazole, H2 receptor antagonists, and quinolones.

Probenecid may prolong or enhance the action of oral sulfonylureas and thereby increase the risk of hypoglycemia.